Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

NCT01151215 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

482

Enrollment

INDUSTRY

Sponsor class

Stopped Futility

Conditions

Neoplasms
Breast Neoplasms
Breast Cancer

Interventions

DRUG: AZD8931
DRUG: anastrozole
DRUG: Placebo

Sponsor

AstraZeneca